Cookies on this site
This website uses cookies to give you the best experience online and to provide anonymised, aggregated site usage data. You can find out what cookies we use, what they do and how you can disable them in our Cookie Policy. By browsing this website and closing this message, you consent to the use of cookies in accordance with our Cookie Policy unless you have disabled them.

Close this message

Success

Thanks for registering for future updates.
Continue

Overexpression of IL-13 in AD Skin

In 2 studies, IL-13 was found to be expressed at higher levels than IL-4 in AD skin.1,2

IL-13 Expression is Higher Than IL-4 in AD Skin1

Expression of IL-4 and IL-13 mRNA in skin samples1

Graphic created by ADKeySuspect.com highlighting that IL-13 is more elevated than IL-4 in AD skin. Expression of IL-4 was present in 11% of skin lesions.

Total skin samples n=28

  • IL-13 mRNA expression was present in 27/28 (96%) of skin lesions1
  • IL-4 mRNA expression was present in 3/28 (11%) of skin lesions1
    • One study showed that IL-13 was more elevated than IL-4 in AD skin; mRNA expression of IL-4 was present in 11% of AD skin lesions1

IL-13 is Overexpressed in AD Skin2

Table created by ADKeySuspect.com highlighting a study of skin samples taken from 90 patients with atopic dermatitis and 20 healthy controls to assess protein levels in lesional skin using a skin–tape stripping methodology; the data demonstrated high levels of IL-13 in all skin samples and low or undetectable IL-4 levels

  • IL-4 was detected in 41/90 (46%) patients
    • In the other study, skin samples were taken from 90 patients with AD and 20 healthy controls to assess protein levels in lesional skin using a skin–tape stripping methodology; the study demonstrated high levels of IL-13 in all skin samples and low or undetectable IL-4 levels2

These results suggest that AD is driven by IL-13 rather than by IL-41,2

A growing body of evidence supports the relative overexpression of IL-13 in AD skin; further research shows how these elevated levels relate to disease severity.3,4

SEE HOW IL-13 CORRELATES WITH SEVERITY

  1. Tazawa T, Sugiura H, Sugiura Y, Uehara M. Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis. Arch Dermatol Res. 2004;295(11):459-464.
  2. Koppes SA, Brans R, Ljubojevic Hadzavdic S, Frings-Dresen MH, Rustemeyer T, Kezic S. Stratum corneum tape stripping: monitoring of inflammatory mediators in atopic dermatitis patients using topical therapy. Int Arch Allergy Immunol. 2016;170(3):187-193.
  3. Tsoi LC, Rodriguez E, Degenhardt F, et al. Atopic dermatitis is an IL-13-dominant disease with greater molecular heterogeneity compared to psoriasis. J Invest Dermatol. 2019;139(7):1480-1489.
  4. Szegedi K, Lutter R, Res PC, et al. Cytokine profiles in interstitial fluid from chronic atopic dermatitis skin. J Eur Acad Dermatol Venereol. 2015;29(11):2136-2144.